Damon Runyon's $2.3M Backs High-Risk, High-Reward Cancer Projects | GenomeWeb

NEW YORK (GenomeWeb News) – The Damon Runyon Cancer Research Foundation has awarded $2.3 million to fund several early-career scientists who are developing novel technologies for diagnosing, preventing, and treating cancer, DRCR said yesterday.

The new Damon Runyon Rachleff Innovation Award winners each will receive $450,000 over three years to pursue projects involving a range of molecular, genomic, and other research tools for combating cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.